N-[(1S)-2-deuterio-1-[5-(2,2,2-trifluoroethoxy)-2-pyridinyl]ethyl]-2-[4-(3-methylpyrazin-2-yl)phenyl]acetamide
C22H21F3N4O2 — CID 51035978
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(1S)-2-deuterio-1-[5-(2,2,2-trifluoroethoxy)-2-pyridinyl]ethyl]-2-[4-(3-methylpyrazin-2-yl)phenyl]acetamide
N-[(1S)-2-deuterio-1-[5-(2,2,2-trifluoroethoxy)-2-pyridinyl]ethyl]-2-[4-(3-methylpyrazin-2-yl)phenyl]acetamide (PubChem CID 51035978) has the molecular formula C22H21F3N4O2 and a molecular weight of 431.44 g/mol. Its IUPAC name is N-[(1S)-2-deuterio-1-[5-(2,2,2-trifluoroethoxy)-2-pyridinyl]ethyl]-2-[4-(3-methylpyrazin-2-yl)phenyl]acetamide.
Molecular Properties
| Compound Name | N-[(1S)-2-deuterio-1-[5-(2,2,2-trifluoroethoxy)-2-pyridinyl]ethyl]-2-[4-(3-methylpyrazin-2-yl)phenyl]acetamide |
|---|---|
| PubChem CID | 51035978 |
| Molecular Formula | C22H21F3N4O2 |
| Molecular Weight | 431.44 g/mol |
| Exact Mass | 431.17 |
| IUPAC Name | N-[(1S)-2-deuterio-1-[5-(2,2,2-trifluoroethoxy)-2-pyridinyl]ethyl]-2-[4-(3-methylpyrazin-2-yl)phenyl]acetamide |
| SMILES | [2H]C[C@H](NC(=O)Cc1ccc(-c2nccnc2C)cc1)c1ccc(OCC(F)(F)F)cn1 |
| InChI | InChI=1S/C22H21F3N4O2/c1-14(19-8-7-18(12-28-19)31-13-22(23,24)25)29-20(30)11-16-3-5-17(6-4-16)21-15(2)26-9-10-27-21/h3-10,12,14H,11,13H2,1-2H3,(H,29,30)/t14-/m0/s1/i1D |
| InChIKey | OURCOVUGQRXRTE-VVKGUEAQSA-N |
| XLogP | 4.21 |
| TPSA | 77.00 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 431.44 |
| LogP ≤ 5 | 4.21 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 51035978 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.